Delivery Order SPE2DX22D0010-SPE2D826FAQ82
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 18, 2025, for the supply of Adzenys XR-ODT 18.8 mg tablets (30-unit dose packages) at a ceiling value of $1,022.24. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and carries no set-aside designation, indicating it was awarded through open competition. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $4,143.14 to AmerisourceBergen Drug Corp for ADZENYS XR-ODT 18.8 mg tablets (30-count unit dose packages) on October 21, 2025, with completion scheduled for October 22, 2025. This firm fixed price contract was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems,...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,521.90 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 5, 2025. The delivery order, issued under a firm fixed price contract type, covers the supply of ADZENYS XR ODT Tablets 1's 6.3MG, a prescription medication used in the treatment of attention-deficit/hyperactivity disorder....
- The Defense Logistics Agency Medical Supply Chain awarded a $1,722.72 delivery order to AmerisourceBergen Drug Corp for ADZENYS XR 12.5MG tablets (30-count) on June 20, 2025, with an ultimate completion date of June 23, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle valued through December 2026. The order will be fulfilled from...
- This delivery order, awarded on August 18, 2025, represents a competitively awarded, firm fixed-price contract for pharmaceutical supplies valued at $9,107.57. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected to supply Adzenys XR ODT tablets (1's, 18.8mg), a medication used in the treatment of attention-deficit/hyperactivity disorder. The contract is classified as a non-set-aside award and carries an ultimate completion...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for supply of ADZENYS XR ODT tablets (amphetamine extended-release orally disintegrating tablets) at a ceiling value of $1,968.19. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under AmerisourceBergen's existing pharmaceutical supply contract. The order is scheduled for completion by September 22, 2025, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Adzenys XR-ODT 18.8 mg tablets in unit dose packaging (30-count). This competitively awarded, non-set-aside contract carries a ceiling value of $2,246.98 and represents a firm fixed-price delivery order with an ultimate completion date of October 28, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major...
- This is a $1,119.16 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADZENYS XR-ODT 6.3 MG TABLET UD 30S, a prescription medication, with a completion date of February 25, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,770.93 contract is for the supply of ADZENYS XR-ODT 18.8 MG TABLET UD 30S, a pharmaceutical product, with a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,865.67 to AmerisourceBergen Drug Corp for the supply of Adzenys XR-ODT 12.5 mg tablets (30-count unit dose packages) with a completion date of September 30, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAQ82Delivery Order
This delivery order, awarded on October 27, 2025, to AmerisourceBergen Drug Corp represents a $1,612.12 firm fixed-price purchase of ADZENYS XR ODT Tablets (6.3 mg) for the Defense Logistics Agency's Medical Supply Chain. The award is non-competitive and is expected to be completed by October 28, 2025. As a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), this delivery order leverages the company's established pharmaceutical supply agreements to provide critical medications to military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a primary vendor for federal medical procurement through its comprehensive supply portfolio spanning brand-name and generic medications, vaccines, and specialized medical devices. The company's extensive experience fulfilling competitive delivery orders for the Defense Logistics Agency demonstrates its capability to meet federal healthcare requirements across multiple therapeutic domains. This particular order for ADZENYS XR ODT—an extended-release medication used in treating ADHD—supports the Military Health System's pharmaceutical needs through the firm fixed-price delivery order mechanism established under AmerisourceBergen's prime vendor contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 10/27/25 |